Amgen Confirms Launch Of First US Eculizumab Rival

Debuts Bkemv Interchangeable Biosimilar To Soliris

 
• By Dave Wallace

Amgen has confirmed to Generics Bulletin details of its launch of Bkemv, the first US biosimilar to Soliris.

Amgen has launched its Soliris biosimilar in the US (Shutterstock)

More from Biosimilars

More from Business